A Burkholderia cepacia complex non-ribosomal peptide-synthesized toxin is hemolytic and required for full virulence

Virulence

Volumn 3, Issue 3, 2012, Pages 286-298

  Thomson, Euan L S ^a   Dennis, Jonathan J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Bacterial pathogenesis; Bacterial toxin; Burkholderia; Burkholderia cepacia; Hemolysin; Mutagenesis; Non ribosomal peptide synthesis

Indexed keywords

ANTIFUNGAL AGENT; GLYCOSYLTRANSFERASE; NONRIBOSOMAL PEPTIDE SYNTHETASE; PROTEINASE; TRIACYLGLYCEROL LIPASE; VIRULENCE FACTOR; HEMOLYSIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BURKHOLDERIA; BURKHOLDERIA CEPACIA COMPLEX; GENE CLUSTER; HEMOLYSIS; MORTALITY; NONHUMAN; ANIMAL; BIOSYNTHESIS; BURKHOLDERIA INFECTION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; LEPIDOPTERA; METABOLISM; MICROBIOLOGY; MULTIGENE FAMILY; NONRIBOSOMAL PEPTIDE SYNTHESIS; PATHOGENICITY; SURVIVAL; VIRULENCE;

BACTERIA (MICROORGANISMS); BURKHOLDERIA; BURKHOLDERIA CEPACIA; BURKHOLDERIA CEPACIA COMPLEX; GALLERIA MELLONELLA;

ANIMALS; BIOSYNTHETIC PATHWAYS; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA INFECTIONS; HEMOLYSIN PROTEINS; HEMOLYSIS; HUMANS; LEPIDOPTERA; MULTIGENE FAMILY; PEPTIDE BIOSYNTHESIS, NUCLEIC ACID-INDEPENDENT; SURVIVAL ANALYSIS; VIRULENCE; VIRULENCE FACTORS;

EID: 84862900584     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.19355     Document Type: Article

References (44)

1. Jacobsen CS, Pedersen JC. Mineralization of 2,4-dichlorophenoxyacetic acid (2,4-D) in soil inoculated with Pseudomonas cepacia DBO1(pRO101), Alcaligenes eutrophus AEO106(pRO101) and Alcaligenes eutrophus JMP134(pJP4): effects of inoculation level and substrate concentration. Biodegradation 1991-1992; 2: 253-63; PMID:1282056; http://dx.doi.org/10.1007/ BF00114557
2. Keyser P, Pujar BG, Eaton RW, Ribbons DW. Biodegradation of the phthalates and their esters by bacteria. Environ Health Perspect 1976; 18:159-66; PMID:829485; http://dx.doi.org/10.1289/ehp.7618159
3. Abe M, Nakazawa T. Characterization of hemolytic and antifungal substance, cepalycin, from Pseudomonas cepacia. Microbiol Immunol 1994; 38:1-9; PMID:7519715
4. el-Banna N, Winkelmann G. Pyrrolnitrin from Burkholderia cepacia: antibiotic activity against fungi and novel activities against streptomycetes. J Appl Microbiol 1998; 85:69-78; PMID:9721657; http://dx. doi.org/10.1046/j.1365-2672.1998.00473.x
5. Kerr J. Inhibition of fungal growth by Pseudomonas aeruginosa and Pseudomonas cepacia isolated from patients with cystic fibrosis. J Infect 1994; 28:305-10; PMID:7522262; http://dx.doi.org/10.1016/S0163-4453(94)91943-7
6. Li X, Yu HY, Lin YF, Teng HM, Du L, Ma GG. Morphological changes of Fusarium oxysporum induced by CF66I, an antifungal compound from Burkholderia cepacia. Biotechnol Lett 2010; 32:1487-95; PMID: 20495943; http://dx.doi.org/10.1007/s10529-010-0316-7
7. Lim Y, Suh JW, Kim S, Hyun B, Kim C, Lee CH. Cepacidine A, a novel antifungal antibiotic produced by Pseudomonas cepacia. II. Physico-chemical properties and structure elucidation. J Antibiot (Tokyo) 1994; 47:1406-16; PMID:7531194
8. Caballero-Mellado J, Onofre-Lemus J, Estrada-de Los Santos P, Martínez-Aguilar L. The tomato rhizosphere, an environment rich in nitrogen-fixing Burkholderia species with capabilities of interest for agriculture and bioremediation. Appl Environ Microbiol 2007; 73: 5308-19; PMID:17601817; http://dx.doi.org/10. 1128/AEM.00324-07
9. Mahenthiralingam E, Urban TA, Goldberg JB. The multifarious, multireplicon Burkholderia cepacia complex. Nat Rev Microbiol 2005; 3:144-56; PMID: 15643431; http://dx.doi.org/10.1038/nrmicro1085
10. Burns JL, Wadsworth CD, Barry JJ, Goodall CP. Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance. Antimicrob Agents Chemother 1996; 40:307-13; PMID:8834871
11. Buroni S, Pasca MR, Flannagan RS, Bazzini S, Milano A, Bertani I, et al. Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance. BMC Microbiol 2009; 9:200; PMID:19761586; http://dx.doi.org/10.1186/1471-2180-9-200
12. Rose H, Baldwin A, Dowson CG, Mahenthiralingam E. Biocide susceptibility of the Burkholderia cepacia complex. J Antimicrob Chemother 2009; 63:502-10; PMID:19153076; http://dx.doi.org/10.1093/jac/dkn540
13. LiPuma JJ, Dasen SE, Nielson DW, Stern RC, Stull TL. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 1990; 336:1094-6; PMID:1977981; http://dx.doi.org/ 10.1016/0140-6736(90)92571-X
14. LiPuma JJ, Spilker T, Gill LH, Campbell PW, 3rd, Liu L, Mahenthiralingam E. Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am J Respir Crit Care Med 2001; 164:92-6; PMID:11435245
15. Zhou J, Chen Y, Tabibi S, Alba L, Garber E, Saiman L. Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis. Antimicrob Agents Chemother 2007; 51:1085-8; PMID:17158942; http://dx.doi.org/ 10.1128/AAC.00954-06
16. Estivariz CF, Bhatti LI, Pati R, Jensen B, Arduino MJ, Jernigan D, et al. An outbreak of Burkholderia cepacia associated with contamination of albuterol and nasal spray. Chest 2006; 130:1346-53; PMID:17099009; http://dx.doi.org/10.1378/chest.130.5.1346
17. Gini G. [Hospital infection caused by Pseudomonas cepacia originating from the use of contaminated disinfectant soap]. Rev Latinoam Microbiol 1986; 28:197-200; PMID:3589199
18. Romero-Gómez MP, Quiles-Melero MI, Peña García P, Gutiérrez Altes A, García de Miguel MA, Jiménez C, et al. Outbreak of Burkholderia cepacia bacteremia caused by contaminated chlorhexidine in a hemodialysis unit. Infect Control Hosp Epidemiol 2008; 29:377-8; PMID:18462153; http://dx.doi.org/10.1086/529032
19. Burns JL, Jonas M, Chi EY, Clark DK, Berger A, Griffith A. Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia. Infect Immun 1996; 64:4054-9; PMID:8926068
20. Chiu CH, Ostry A, Speert DP. Invasion of murine respiratory epithelial cells in vivo by Burkholderia cepacia. J Med Microbiol 2001; 50:594-601; PMID:11444769
21. Hunt TA, Kooi C, Sokol PA, Valvano MA. Identification of Burkholderia cenocepacia genes required for bacterial survival in vivo. Infect Immun 2004; 72:4010-22; PMID:15213146; http://dx.doi.org/10.1128/IAI. 72.7.4010-4022.2004
22. Maloney KE, Valvano MA. The mgtC gene of Burkholderia cenocepacia is required for growth under magnesium limitation conditions and intracellular survival in macrophages. Infect Immun 2006; 74:5477-86; PMID:16988222; http://dx.doi.org/10.1128/IAI. 00798-06
23. Nakazawa T, Yamada Y, Ishibashi M. Characterization of hemolysin in extracellular products of Pseudomonas cepacia. J Clin Microbiol 1987; 25:195-8; PMID: 3818916
24. Vasil ML, Krieg DP, Kuhns JS, Ogle JW, Shortridge VD, Ostroff RM, et al. Molecular analysis of hemolytic and phospholipase C activities of Pseudomonas cepacia. Infect Immun 1990; 58:4020-9; PMID:2254027
25. Hutchison ML, Poxton IR, Govan JR. Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes. Infect Immun 1998; 66:2033-9; PMID:9573086
26. Fehlner-Gardiner CC, Hopkins TMH, Valvano MA. Identification of a general secretory pathway in a human isolate of Burkholderia vietnamiensis (formerly B. cepacia complex genomovar V) that is required for the secretion of hemolysin and phospholipase C activities. Microb Pathog 2002; 32:249-54; PMID: 12071681; http://dx.doi.org/10.1006/mpat.2002.0503
27. Bevivino A, Dalmastri C, Tabacchioni S, Chiarini L, Belli ML, Piana S, et al. Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy: genomovar status and distribution of traits related to virulence and transmissibility. J Clin Microbiol 2002; 40:846-51; PMID:11880403; http://dx.doi.org/ 10.1128/JCM.40.3.846-851.2002
28. Carvalho AP, Ventura GM, Pereira CB, Leão RS, Folescu TW, Higa L, et al. Burkholderia cenocepacia, B. multivorans, B. ambifaria and B. vietnamiensis isolates from cystic fibrosis patients have different profiles of exoenzyme production. APMIS 2007; 115:311-8; PMID:17504297; http://dx.doi.org/10.1111/j.1600-0463.2007.apm_603.x
29. Hammer PE, Burd W, Hill DS, Ligon JM, van Pée K. Conservation of the pyrrolnitrin biosynthetic gene cluster among six pyrrolnitrin-producing strains. FEMS Microbiol Lett 1999; 180:39-44; PMID:10547442; http://dx.doi.org/10.1111/j.1574-6968.1999.tb08775.x
30. Shoji J, Hinoo H, Kato T, Hattori T, Hirooka K, Tawara K, et al. Isolation of cepafungins I, II and III from Pseudomonas species. J Antibiot (Tokyo) 1990; 43:783-7; PMID:2387772
31. Lee CH, Kim S, Hyun B, Suh JW, Yon C, Kim C, et al. Cepacidine A, a novel antifungal antibiotic produced by Pseudomonas cepacia. I. Taxonomy, production, isolation and biological activity. J Antibiot (Tokyo) 1994; 47: 1402-5; PMID:7531193
32. Gu G, Smith L, Wang N, Wang H, Lu SE. Biosynthesis of an antifungal oligopeptide in Burkholderia contaminans strain MS14. Biochem Biophys Res Commun 2009; 380:328-32; PMID:19167363; http://dx.doi.org/10. 1016/j.bbrc.2009.01.073
33. Lu SE, Novak J, Austin FW, Gu G, Ellis D, Kirk M, et al. Occidiofungin, a unique antifungal glycopeptide produced by a strain of Burkholderia contaminans. Biochemistry 2009; 48:8312-21; PMID:19673482; http://dx.doi.org/10.1021/bi900814c
34. Tawfik KA, Jeffs P, Bray B, Dubay G, Falkinham JO, Mesbah M, et al. Burkholdines 1097 and 1229, potent antifungal peptides from Burkholderia ambifaria 2.2N. Org Lett 2010; 12:664-6; PMID:20085289; http://dx. doi.org/10.1021/ol9029269
35. Bisacchi GS, Hockstein DR, Koster WH, Parker WL, Rathnum ML, Unger SE. Xylocandin: a new complex of antifungal peptides. II. Structural studies and chemical modifications. J Antibiot (Tokyo) 1987; 40:1520-9; PMID:3693122
36. Meyers E, Bisacchi GS, Dean L, Liu WC, Minassian B, Slusarchyk DS, et al. Xylocandin: a new complex of antifungal peptides. I. Taxonomy, isolation and biological activity. J Antibiot (Tokyo) 1987; 40:1515-9; PMID:3693121
37. Walsh TA, Ballou DP. Halogenated protocatechuates as substrates for protocatechuate dioxygenase from Pseudomonas cepacia. J Biol Chem 1983; 258:14413-21; PMID:6643491
38. Dennis JJ, Zylstra GJ. Plasposons: modular self-cloning minitransposon derivatives for rapid genetic analysis of gram-negative bacterial genomes. Appl Environ Microbiol 1998; 64:2710-5; PMID:9647854
39. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215:403-10; PMID:2231712
40. Pukatzki S, Ma AT, Sturtevant D, Krastins B, Sarracino D, Nelson WC, et al. Identification of a conserved bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host model system. Proc Natl Acad Sci U S A 2006; 103:1528-33; PMID:16432199; http://dx.doi.org/10.1073/pnas.0510322103
41. Walsh C, Freel Meyers CL, Losey HC. Antibiotic glycosyltransferases: antibiotic maturation and prospects for reprogramming. J Med Chem 2003; 46:3425-36; PMID:12877577; http://dx.doi.org/10.1021/jm030257i
42. Ellis D, Gosai J, Emrick C, Heintz R, Romans L, Gordon D, et al. Occidiofungin's chemical and in vitro potency against Candida species. Antimicrob Agents Chemother 2012; 56:765-9; PMID:22106210; http:// dx.doi.org/10.1128/AAC.05231-11
43. Cardona ST, Valvano MA. An expression vector containing a rhamnose-inducible promoter provides tightly regulated gene expression in Burkholderia cenocepacia. Plasmid 2005; 54:219-28; PMID:15925406; http://dx. doi.org/10.1016/j.plasmid.2005.03.004
44. Seed KD, Dennis JJ. Development of Galleria mellonella as an alternative infection model for the Burkholderia cepacia complex. Infect Immun 2008; 76:1267-75; PMID:18195031; http://dx.doi.org/10. 1128/IAI.01249-07